Rongxiang (Catherine) Tang

rongxiang.bsky.social

08 August 2026 21:01

Thrilled to share a null (yes null!) finding on the associations between neighborhood disadvantage and plasma biomarkers of Alzheimer's disease with @vetsa.bsky.social . www.neurology.org/doi/10.1212/...

NEJM.org

nejm.org

04 August 2026 21:53

Our latest video in partnership with @glaucomflecken.bsky.social summarizes the OVERLORD-MS trial that compared rituximab versus ocrelizumab in newly diagnosed relapsing multiple sclerosis. Read the full study for free: https://nej.md/DrG46 #neurology

Alzheimer's & Dementia Journals

alzdemjournals.bsky.social

03 August 2026 20:26

#DADM Call for Papers Open TODAY! Topic: Biomarkers for Alzheimer's disease co-pathologies ⏰Deadline: March 31, 2027 Submit today! alz-journals.onlinelibrary.wiley.com/hub/journal/...

Jet M.J. Vonk, PhD PhD

jetmjvonk.bsky.social

03 August 2026 20:23

Our new paper in @jamaneurology.com shows that automated analysis of just 1–2 minutes of speech can accurately distinguish primary progressive aphasia variants and reflects their underlying anatomy & pathology, with potential as a practical, interpretable tool to aid diagnosis and disease monitoring

JAMA Neurology

jamaneurology.com

03 August 2026 20:23

In #PrimaryProgressiveAphasia, automated #SpeechAnalysis of a brief picture description task distinguished nonfluent, logopenic, and semantic variants and produced interpretable speech profiles. ja.ma/4w4A2xg